Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

10.8K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.8K
The Unfolded Protein Response01:37

The Unfolded Protein Response

6.6K
The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
6.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Integrative plasma-to-spatial proteomics reveals fibroblast-associated signatures in liver metastatic breast cancer.

Cancer cell international·2026
Same author

Promise and pragmatism of AI in global-scale digital pathology: pan-cancer approaches for clinical practice.

Journal of clinical pathology·2026
Same author

Guidelines for the management of hereditary ATTR amyloidosis 2026.

Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis·2026
Same author

Type 3 innate lymphoid cells dominate the ILC compartment in endstage lung disease.

Frontiers in immunology·2026
Same author

Multiple human transgenes prolong survival of triple-carbohydrate knockout porcine kidney xenografts in nonhuman primates.

Nature communications·2026
Same author

Intestinal resident effector-memory CD4 T cells on the adaptive-innate spectrum comprise IL-18 reactivity and adaptive CMV specificity.

Science advances·2026

Related Experiment Video

Updated: Mar 2, 2026

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging
09:37

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging

Published on: July 14, 2016

8.8K

Exogenous alpha 1-antitrypsin down-regulates SERPINA1 expression.

Ahmad Karadagi1, Helene Johansson1, Helen Zemack1

  • 1Division of Transplantation Surgery, Department of Clinical Science, Intervention and Technology (CLINTEC), Karolinska Institute, Karolinska University Hospital Huddinge, Stockholm, Sweden.

Plos One
|May 10, 2017
PubMed
Summary

Alpha-1 antitrypsin (A1AT) augmentation therapy may reduce endogenous A1AT gene expression in patients with A1AT deficiency. This finding suggests potential benefits for liver health in individuals with PiZZ emphysema.

More Related Videos

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
10:21

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

935
Monitoring Neutrophil Elastase and Cathepsin G Activity in Human Sputum Samples
09:23

Monitoring Neutrophil Elastase and Cathepsin G Activity in Human Sputum Samples

Published on: May 21, 2021

18.5K

Related Experiment Videos

Last Updated: Mar 2, 2026

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging
09:37

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging

Published on: July 14, 2016

8.8K
Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
10:21

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

935
Monitoring Neutrophil Elastase and Cathepsin G Activity in Human Sputum Samples
09:23

Monitoring Neutrophil Elastase and Cathepsin G Activity in Human Sputum Samples

Published on: May 21, 2021

18.5K

Area of Science:

  • Biochemistry
  • Genetics
  • Pulmonology

Background:

  • Alpha-1 antitrypsin (A1AT) deficiency (A1ATD) is a genetic disorder leading to emphysema.
  • Current A1AT augmentation therapy aims to increase serum A1AT levels and protect lungs.
  • The impact of A1AT therapy on A1AT gene (SERPINA1) expression, particularly in the liver, is not well understood.

Purpose of the Study:

  • To investigate the effect of purified human plasma A1AT on SERPINA1 gene expression.
  • To explore potential hepatic benefits of A1AT therapy in A1ATD patients.

Main Methods:

  • Primary human hepatocytes from A1AT deficient and control donors were treated with A1AT +/- Oncostatin M (OSM).
  • SERPINA1 mRNA levels were assessed in lung tissues from PiZZ emphysema patients with and without A1AT therapy.
  • SERPINA1 expression was analyzed in human peripheral blood mononuclear cells (PBMCs) from healthy donors treated with A1AT.

Main Results:

  • Purified A1AT dose-dependently reduced SERPINA1 expression in human hepatocytes, an effect enhanced by OSM.
  • A trend towards lower SERPINA1 expression was observed in lung tissues of PiZZ emphysema patients receiving A1AT therapy (P=0.0539).
  • Exogenous A1AT reduced endogenous SERPINA1 expression in both naive and LPS-stimulated human PBMCs.

Conclusions:

  • Exogenous A1AT protein can suppress its own endogenous gene expression.
  • A1AT augmentation may reduce dysfunctional Z-A1AT expression in the liver, suggesting potential therapeutic benefits beyond lung protection.
  • Further research is warranted to confirm these findings and explore hepatic implications.